Abstract
Small glucose-modified liposomes (GMLs) were loaded with magnetic Fe3O4 nanoparticles (MNPs) and fluorescein using a standard thin layer preparation procedure and a varying lipid/MNPs ratio. The liposomes were characterized with TEM and DLS measurements, and MNPs encapsulation rate was determined using ICP-OES. Prepared liposomes were stored at 5 °C for 30 days and subsequently exposed to an external magnetic field (20 mT) with varying exposure times (2‒20 min), at room temperature. The release of fluorescein from GMLs induced by the magnetic field exposures was quantified, showing a high release rate (25‒85%) depending on the concentration of MNPs in GMLs. EPR measurements were conducted during the liposomes storage period in order to provide semi-quantitative information of possible MNPs oxidation from Fe3O4 to Fe2O3 inside the liposomes, impacting MNPs magnetic properties. In contrast to the MNPs water dispersion, no significant change in the EPR signal of MNPs encapsulated inside GMLs was detected over the course of 30 days. The data presented in this study indicate that GMLs loaded with MNPs maintain a high stability for prolonged periods of time and that this delivery system may be used for magnetically assisted controlled drug release.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Laviano A, Rossi Fanelli F (2012) Toxicity in chemotherapy — when less is more N Engl J Med. 366: 2319–2320. https://doi.org/10.1056/nejmcibr1202395.
Iwamoto T (2013) Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. Biol Pharm Bull 36:715–718. https://doi.org/10.1248/bpb.b12-01102
Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalt Trans 47:6645–6653. https://doi.org/10.1039/c8dt00838h
Sawyers C (2004) Targeted cancer therapy. Nature 432:294–297. https://doi.org/10.1038/nature03095
Rodzinski A, Guduru R, Liang P, Hadjikhani A, Stewart T, Stimphil E, Runowicz C, Cote R, Altman N, Datar R, Khizroev S (2016) Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles. Sci Rep 6:1–14. https://doi.org/10.1038/srep20867
Liu JF, Jang B, Issadore D, Tsourkas A (2019) Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting, Wiley Interdiscip. Rev. Nanomedicine. NanoBiotechnology 11:1–18. https://doi.org/10.1002/wnan.1571
Bennett DE, Lamparski H, O’brien DF (1994) Photosensitive liposomes. J Liposome Res. 4: 331–348. https://doi.org/10.3109/08982109409037048
Ginsberg R, Pilkiewicz F, Ginsberg R, Brenner DE, Tung Y, Petrelli N (1993) Initial Clinical (phase i) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res 53:2796–2802
Cvjetinović Đ, Prijović Ž, Janković D, Radović M, Mirković M, Milanović Z, Mojović M, Škalamera Đ, Vranješ-Đurić S (2021) Bioevaluation of glucose-modified liposomes as a potential drug delivery system for cancer treatment using 177-Lu radiotracking. J Control Release 332:301–311. https://doi.org/10.1016/j.jconrel.2021.03.006
Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:1–33. https://doi.org/10.3390/pharmaceutics9020012
Zhang Y, Xuan S, Owoseni O, Omarova M, Li X, Saito ME, He J, McPherson GL, Raghavan SR, Zhang D, John VT (2017) Amphiphilic polypeptoids serve as the connective glue to transform liposomes into multilamellar structures with closely spaced bilayers. Langmuir 33:2780–2789. https://doi.org/10.1021/acs.langmuir.6b04190
Blume G, Cevc G (1990) Liposomes for the sustained drug release in vivo. BBA - Biomembr 1029:91–97. https://doi.org/10.1016/0005-2736(90)90440-Y
Bangham AD (1993) Liposomes: the Babraham connection. Chem Phys Lipids 64:275–285. https://doi.org/10.1016/0009-3084(93)90071-A
Madni MA, Sarfraz M, Rehman M, Ahmad M, Akhtar N, Ahmad S, Tahir N, Ijaz S, Al-Kassas R, Löbenberg R (2014) Liposomal drug delivery: a versatile platform for challenging clinical applications. J Pharm Pharm Sci 17: 401–426. https://doi.org/10.18433/j3cp55
Mozafari MR, Reed CJ, Rostron C (2007) Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents. Pharmazie 62:205–209. https://doi.org/10.1691/ph.2007.3.6045
Allen TM, Martin FJ (2004) Advantages of liposomal delivery systems for anthracyclines. Semin Oncol 31:5–15. https://doi.org/10.1053/j.seminoncol.2004.08.001
Gabizon A, Shmeeda H, Barenholz Y (2003) Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 42:419–436. https://doi.org/10.2165/00003088-200342050-00002
Balazsovits JAE, Mayer LD, Bally MB, Cullis PR, McDonell M, Ginsberg RS, Falk RE (1989) Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother Pharmacol 23:81–86. https://doi.org/10.1007/BF00273522
He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–3666. https://doi.org/10.1016/j.biomaterials.2010.01.065
Zumbuehl O, Weder HG (1981) Liposomes of controllable size in the range of 40 to 180 nm by defined dialysis of lipid/detergent mixed micelles. BBA - Biomembr 640:252–262. https://doi.org/10.1016/0005-2736(81)90550-2
Ren H, He Y, Liang J, Cheng Z, Zhang M, Zhu Y, Hong C, Qin J, Xu X, Wang J (2019) Role of liposome size, surface charge, and pegylation on rheumatoid arthritis targeting therapy. ACS Appl Mater Interfaces 11:20304–20315. https://doi.org/10.1021/acsami.8b22693
Chono S, Tanino T, Seki T, Morimoto K (2007) Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol 59:75–80. https://doi.org/10.1211/jpp.59.1.0010
Litzinger DC, Buiting AMJ, van Rooijen N, Huang L (1994) Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. BBA - Biomembr 1190:99–107. https://doi.org/10.1016/0005-2736(94)90038-8
Moghimi SM, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–478. https://doi.org/10.1016/S0163-7827(03)00033-X
Li XM, Ding LY, Xu Y, Wang Y, Ping QN (2009) Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 373:116–123. https://doi.org/10.1016/j.ijpharm.2009.01.023
Ancey PB, Contat C, Meylan E (2018) Glucose transporters in cancer – from tumor cells to the tumor microenvironment. FEBS J 285:2926–2943. https://doi.org/10.1111/febs.14577
Szablewski L (1835) Expression of glucose transporters in cancers. Biochim Biophys Acta - Rev Cancer 2013:164–169. https://doi.org/10.1016/j.bbcan.2012.12.004
Adekola K, Rosen ST, Shanmugam M (2012) Glucose transporters in cancer metabolism. Curr Opin Oncol 24:650–654. https://doi.org/10.1097/CCO.0b013e328356da72
Maisey MN (2002) Overview of clinical PET. Br J Radiol 75:S1–S5. https://doi.org/10.1259/bjr.75.suppl_9.750001
Chen Y, Bose A, Bothun GD (2010) Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating. ACS Nano 4:3215–3221. https://doi.org/10.1021/nn100274v
Biltonen RL, Lichtenberg D (1993) The use of differential scanning calorimetry as a tool to characterize liposome preparations. Chem Phys Lipids 64:129–142. https://doi.org/10.1016/0009-3084(93)90062-8
Qin Y, Fan W, Chen H, Yao N, Tang W, Tang J, Yuan W, Kuai R, Zhang Z, Wu Y, He Q (2010) In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes. J Drug Target 18:536–549. https://doi.org/10.3109/10611861003587235
Perić M, Radović M, Mirković M, Nikolić AS, Iskrenović P, Janković D, Vranješ-Đurić S (2019) The analysis of 2,3-dicarboxypropane-1,1-diphosphonic acid-coated magnetite nanoparticles under an external magnetic field and their radiolabeling for possible theranostic applications. New J Chem 43:5932–5939. https://doi.org/10.1039/c8nj06478d
Mady MM, Fathy MM, Youssef T, Khalil WM (2012) Biophysical characterization of gold nanoparticles-loaded liposomes. Phys Medica 28:288–295. https://doi.org/10.1016/j.ejmp.2011.10.001
Adams S, Bonabi S, Allen A, Roseman G, Ramirez AP, Millhauser G, Zhang JZ (2019) The effect of polymer and gold functionalization on the magnetic properties of magnetite nanoparticles, Biomed. Spectrosc. Imaging 7:115–124. https://doi.org/10.3233/BSI-180182
Noginov MM, Noginova N, Amponsah O, Bah R, Rakhimov R, Atsarkin VA (2008) Magnetic resonance in iron oxide nanoparticles: quantum features and effect of size. J Magn Magn Mater 320:2228–2232. https://doi.org/10.1016/j.jmmm.2008.04.154
Can MM, Coşkun M, Firat T (2012) A comparative study of nanosized iron oxide particles; Magnetite (Fe 3O 4), maghemite (γ-Fe 2O 3) and hematite (α-Fe 2O 3), using ferromagnetic resonance. J Alloys Compd 542:241–247. https://doi.org/10.1016/j.jallcom.2012.07.091
Upadhyay RV, Srinivas D, Mehta RV (2000) Magnetic resonance in nanoscopic particles of a ferrofluid. J Magn Magn Mater 214:105–111. https://doi.org/10.1016/S0304-8853(99)00811-2
Sastry MD, Nagar YC, Bhushan B, Mishra KP, Balaram V, Singhvi AK (2008) An unusual radiation dose dependent EPR line at geff = 2.54 in feldspars: Possible evidence of Fe3+O2- ↔ Fe 2+O- and exchange coupled Fe3+-Fe 2+-nO-, J Phys Condens Matter. 20. https://doi.org/10.1088/0953-8984/20/02/025224.
Anand M, Carrey J, Banerjee V (2016) Spin morphologies and heat dissipation in spherical assemblies of magnetic nanoparticles. Phys Rev B 94:1–12. https://doi.org/10.1103/PhysRevB.94.094425
Tan RP, Carrey J, Respaud M (2014) Magnetic hyperthermia properties of nanoparticles inside lysosomes using kinetic Monte Carlo simulations: influence of key parameters and dipolar interactions, and evidence for strong spatial variation of heating power. Phys Rev B - Condens Matter Mater Phys. 90: 1–12. https://doi.org/10.1103/PhysRevB.90.214421.
S. Islam, A. Khan, G.M.S. Rahman, H. Aftab, A comparative study on heat dissipation , morphological and magnetic properties of hyperthermia suitable ... Simple Hydrothermal Synthesis and Morphological Study of Magnetic Nanoparticles, 35 (2016) 1047–1053.
Domenech M, Marrero-Berrios I, Torres-Lugo M, Rinaldi C (2013) Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields. ACS Nano 7:5091–5101. https://doi.org/10.1021/nn4007048
Sanchez C, El Hajj Diab D, Connord V, Clerc P, Meunier E, Pipy B, Payré B, Tan RP, Gougeon M, Carrey J, Gigoux V, Fourmy D (2014) Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death. ACS Nano. 8: 1350–1363. https://doi.org/10.1021/nn404954s.
Guo H, Chen W, Sun X, Liu YN, Li J, Wang J (2015) Theranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic field. Carbohydr Polym 118:209–217. https://doi.org/10.1016/j.carbpol.2014.10.076
Anand M (2021) Hysteresis in two dimensional arrays of magnetic nanoparticles. J Magn Magn Mater 540:168461. https://doi.org/10.1016/j.jmmm.2021.168461
Anand M (2020) Hysteresis in a linear chain of magnetic nanoparticles. J Appl Phys 128. https://doi.org/10.1063/5.0010217
Mirković M, Radović M, Stanković D, Milanović Z, Janković D, Matović M, Jeremić M, Antić B, Vranješ-Đurić S (2019) 99mTc–bisphosphonate–coated magnetic nanoparticles as potential theranostic nanoagent. Mater Sci Eng C 102:124–133. https://doi.org/10.1016/j.msec.2019.04.034
Zhang JQ, Zhang ZR, Yang H, Tan QY, Qin SR, Qiu XL (2005) Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm Res 22:573–583. https://doi.org/10.1007/s11095-005-2496-8
Ye H, Tong J, Liu J, Lin W, Zhang C, Chen K, Zhao J, Zhu W (2016) Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: a possible mechanism with potential for clinical application. Oncotarget 7: 43762–43778. https://doi.org/10.18632/oncotarget.9671.
Wang X, Yang R, Yuan C, An Y, Tang Q, Chen D (2018) Preparation of folic acid-targeted temperature-sensitive magnetoliposomes and their antitumor effects in vitro and in vivo, target. Oncol 13:481–494. https://doi.org/10.1007/s11523-018-0577-y
Acknowledgements
The authors thank Centre for Electron Microscopy (Faculty of Biology, University of Belgrade) for performing the TEM measurements.
Funding
This work was supported by the Ministry of Education, Science and Technological Development of Republic of Serbia Contract number: 451-03-9/2021-14/200146.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cvjetinović, Đ., Milanović, Z., Mirković, M. et al. Magnetically induced controlled release from glucose-modified liposomes loaded with Fe3O4 nanoparticles. J Nanopart Res 23, 252 (2021). https://doi.org/10.1007/s11051-021-05375-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-021-05375-2